Home Other Building Blocks 4-Phenylpyridine

4-Phenylpyridine

CAS No.:
939-23-1
Catalog Number:
AG00344Z
Molecular Formula:
C11H9N
Molecular Weight:
155.1959
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
96%
In Stock USA
United States
$13
- +
5g
96%
In Stock USA
United States
$44
- +
25g
96%
In Stock USA
United States
$138
- +
100g
96%
In Stock USA
United States
$450
- +
500g
96%
In Stock USA
United States
$1813
- +
Product Description
Catalog Number:
AG00344Z
Chemical Name:
4-Phenylpyridine
CAS Number:
939-23-1
Molecular Formula:
C11H9N
Molecular Weight:
155.1959
MDL Number:
MFCD00006420
IUPAC Name:
4-phenylpyridine
InChI:
InChI=1S/C11H9N/c1-2-4-10(5-3-1)11-6-8-12-9-7-11/h1-9H
InChI Key:
JVZRCNQLWOELDU-UHFFFAOYSA-N
SMILES:
c1ccc(cc1)c1ccncc1
EC Number:
213-357-4
UNII:
452KD9YCG7
Properties
Complexity:
121  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
155.073g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
155.2g/mol
Monoisotopic Mass:
155.073g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
12.9A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.6  
Literature
Title Journal
Photophysical and electrochemical properties of platinum(II) complexes bearing a chromophore-acceptor dyad and their photocatalytic hydrogen evolution. Dalton transactions (Cambridge, England : 2003) 20120721
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition. Journal of medicinal chemistry 20120614
trans-Dichloridobis(4-phenyl-pyridine-κN)palladium(II). Acta crystallographica. Section E, Structure reports online 20111201
Direct observation of a {Re6(μ3-S)8} core-to-ligand charge-transfer excited state in an octahedral hexarhenium complex. Inorganic chemistry 20111017
Comparison of molecular conductance between planar and twisted 4-phenylpyridines by means of two-dimensional phase separation of tetraphenylporphyrin templates at a liquid-HOPG interface. Chemical communications (Cambridge, England) 20110807
Vibrational spectroscopic study on some Hofmann-Td type clathrates: Ni(4-phenylpyridine)2M(CN)4·2G (M=Cd or Hg, G=1,4-dioxane). Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110501
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety. Bioorganic & medicinal chemistry 20110401
Dipyrrin based silver [2 + 2] metallamacrocycles. Dalton transactions (Cambridge, England : 2003) 20110114
Mitochondrial dysfunction in Parkinson's disease. Parkinson's disease 20110101
Synthesis and structural and magnetic characterisation of cobalt(ii) complexes of mixed phosphonate-antimonate ligands. Dalton transactions (Cambridge, England : 2003) 20101028
Synthesis, characterization and cytotoxic activities of the [RuCl2(NO)(dppp)(L)]PF6 complexes. Journal of inorganic biochemistry 20100501
Heptacarbonyl-1κC,2κC-(4-phenyl-pyridine-1κN)di-μ-phenyltellurido-1:2κTe:Te-dirhenium(I). Acta crystallographica. Section E, Structure reports online 20100501
Bis(μ-phenyl-tellurido-κTe:Te)bis-[tetra-carbonyl-rhenium(I)]. Acta crystallographica. Section E, Structure reports online 20100501
Tripodal 4-pyridyl-derived host ligands and their metallo-supramolecular chemistry: stella octangula and bowl-shaped assemblies. Inorganic chemistry 20100118
Excited-state properties of octahedral hexarhenium(III) complexes with redox-active N-heteroaromatic ligands. Inorganic chemistry 20100118
1H, 13C and 15N nuclear magnetic resonance coordination shifts in Au(III), Pd(II) and Pt(II) chloride complexes with phenylpyridines. Magnetic resonance in chemistry : MRC 20090801
Thermal- and light-induced spin crossover in novel 2D Fe(II) metalorganic frameworks {Fe(4-PhPy)(2)[M(II)(CN)(x)](y)}.sH(2)O: spectroscopic, structural, and magnetic studies. Inorganic chemistry 20090706
Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs. Drug metabolism and disposition: the biological fate of chemicals 20090301
Syntheses, structures and magnetic properties of a family of metal carboxylate polymers via in situ metal-ligand reactions of benzene-1,2,3-tricarboxylic acid. Dalton transactions (Cambridge, England : 2003) 20090227
Regioselectivity and stereoselectivity of dioxygenase catalysed cis-dihydroxylation of mono- and tri-cyclic azaarene substrates. Organic & biomolecular chemistry 20081107
Synthesis, growth and characterization of a new nonlinear optical material: 4-phenylpyridinium hydrogen squarate (4PHS). Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080401
Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. Journal of neuroinflammation 20080101
N-Phenyl-N-{4-[5-(4-pyrid-yl)-1,3,4-oxadiazol-2-yl]phen-yl}aniline. Acta crystallographica. Section E, Structure reports online 20080101
Dissecting the thermodynamics and cooperativity of ligand binding in cytochrome P450eryF. Journal of the American Chemical Society 20070221
The novel squamosamide derivative (compound FLZ) attenuated 1-methyl, 4-phenyl-pyridinium ion (MPP+)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells. Neuropharmacology 20070201
Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. Molecular neurodegeneration 20070101
Mass spectrometric studies on 4-aryl-1-cyclopropyl-1,2-dihydropyridinyl derivatives: an examination of a novel fragmentation pathway. Journal of mass spectrometry : JMS 20061201
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Simple chip-based interfaces for on-line monitoring of supramolecular interactions by nano-ESI MS. Lab on a chip 20051001
Rhenium(V) complexes with thiolato and dithiolato ligands: synthesis, structures, and monomerization reactions. Inorganic chemistry 20050516
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk). Journal of medicinal chemistry 20050505
Parkinson's disease: the first common neurological disease due to auto-intoxication? QJM : monthly journal of the Association of Physicians 20050301
Autotoxicity, methylation and a road to the prevention of Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20050101
Richness of isomerism in labile octahedral Werner-type cobalt(II) complexes demonstrated by 19F NMR spectroscopy: structure and stability. Magnetic resonance in chemistry : MRC 20040901
Tuning the electronic structures of platinum(II) complexes with a cyclometalating aryldiamine ligand. Inorganic chemistry 20040126
NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability. Journal of medicinal chemistry 20021219
Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists. Journal of medicinal chemistry 20020801
The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. The Journal of biological chemistry 20020621
Tetra-mu-acetato-kappa2O:O'-bis[(4-phenylpyridine-kappaN)copper(II)]. Acta crystallographica. Section C, Crystal structure communications 20020401
Pentacarbonyl(4-phenylpyridine)tungsten(0) and pentacarbonyl(2-phenylpyridine)chromium(0). Acta crystallographica. Section C, Crystal structure communications 20010401
Properties